跳至主要内容
临床试验/NCT05462925
NCT05462925已完成不适用

Point-of-care Prediction of Muscle Responsiveness to Functional Electrical Stimulation Therapy During Neurorehabilitation (sub-study)

University Health Network, Toronto2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2022年7月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
2
主要终点
Muscle strength recovery profile

研究概览

简要总结

Reduced arm and hand function has a significant impact on independence and quality of life after spinal cord injury. Functional electrical stimulation therapy (FES-T) is a treatment that can produce improvements in reaching and grasping function after neurological injuries. However, not all paralyzed muscles respond equally well to the therapy. Currently, therapists cannot predict which muscles will respond, limiting their ability to create a personalized therapy plan that can maximize outcomes while making the best use of the limited treatment time available. The objective of this study is to develop a diagnostic method that will allow therapists to quickly and easily screen muscles in the clinic, in order to predict how they will respond to FES-T.

Participants with cervical spinal cord injury will receive FES-T through the Rocket Family Upper Extremity Clinic at the Toronto Rehabilitation Institute - University Health Network. Muscles receiving training will undergo a electrophysiological examination before the start of therapy, and will then be tracked for strength recovery over the course of 30 sessions. Lastly, signal processing and machine learning techniques will be applied to the electrophysiological data to predict the recovery profile of each muscle.

The significance of this work will be to provide personalized therapy planning in FES-T, leading to more effective use of healthcare resource as well as improved outcomes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cervical spinal cord injury
  • Paralysis or paresis in at least one upper extremity
  • At least 6 months post SCI
  • Able to understand and follow instructions
  • Able to tolerate being in a seated position for a least one hour required to deliver upper limb therapy
  • Willing to attend treatment sessions and all assessment sessions
  • Able to understand and provide informed consent
  • Male and female participants ≥ 18 years of age at the time of enrollment

排除标准

  • Previous history of any other neuromuscular disorder or conditions that may affect motor response
  • Upper extremity injury or condition prior to SCI that limits the function of the hand or arm
  • In the judgment of the medical provider, the participant has medical complications that may interfere with the execution of the study
  • Currently enrolled in another upper limb study and/ or has received MyndMove Therapy within the past 3 months
  • Botulinum toxin injection into affected upper extremity and the muscle targeted by MyndMove® therapy within 3 months prior to the study start. No botulinum toxin injections in the upper extremity during the study treatment.
  • Females who are pregnant or planning to become pregnant in the duration of the trial
  • Regional disorder of the upper extremities such as fracture, dislocation, or joint contractures to less than 50% of the expected range of motion

结局指标

主要结局

Muscle strength recovery profile

时间窗: Muscle strength assessed at each of 30 therapy sessions (3-5 sessions per week).

Change over time in manual muscle testing conducted on each treated muscle.

次要结局

  • Surface electromyography signal features(Baseline (required). End of therapy (6-10 weeks; optional).)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验